SCHEMBL27186983

SCHEMBL27186983

COC(=O)c1cc(C(C)=O)c(OC)c2c[nH]nc12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 5/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.38
▸ POLB P06746 2/20 0.37
▸ NR4A2 P43354 7/20 0.37
▸ HTT P42858 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ USP2 O75604 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.35
▸ MAP2K1 Q02750 1/20 0.35
▸ CA12 O43570 2/20 0.34
▸ CA1 P00915 2/20 0.34
▸ CA2 P00918 2/20 0.34
▸ CA7 P43166 2/20 0.34
▸ CA9 Q16790 2/20 0.34
▸ CA14 Q9ULX7 2/20 0.34
▸ PDK2 Q15119 1/20 0.34
▸ PDK4 Q16654 1/20 0.34
▸ CREBBP Q92793 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27186349 0.83 NR4A2 (0.40) KDM4EALDH1A1HPGDNPSR1POLB
SCHEMBL27186192 0.78 ALDH1A1 (0.34) KDM4EALDH1A1HPGDNPSR1POLB
SCHEMBL27187216 0.76 EGFR (0.39) KDM4EALDH1A1HPGDNPSR1NR4A2
SCHEMBL27186154 0.75 UCHL1 (0.32) KDM4EALDH1A1HPGDNPSR1POLB
SCHEMBL27186177 0.74 PDK2 (0.36) KDM4EALDH1A1HPGDNPSR1NR4A2
SCHEMBL29168359 0.72 AXL (0.31) KDM4EALDH1A1HPGDNPSR1NR4A2
SCHEMBL27186423 0.72 KDM4E (0.42) KDM4ENR4A2MAPTHSD17B10MAP2K1
SCHEMBL27186424 0.71 GCK (0.36) —
SCHEMBL25105227 0.71 KDM4E (0.42) KDM4EPOLBNR4A2MAPTHSD17B10
SCHEMBL27186991 0.70 HSD17B10 (0.50) KDM4EALDH1A1HPGDHTTMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240109887-A1 NOVEL SUBSTITUTED BICYCLIC AZA-HETEROCYCLES AS SOS1 INHIBITORS VIVA STAR BIOSCIENCES (SUZHOU) CO., LTD. (CN) 2024-04-04 — — US disclosed
CN-117651701-A Novel substituted bicyclic aza heterocycles as SOS1 inhibitors 唯久生物技术(苏州)有限公司 2024-03-05 — — CN disclosed
WO-2022187266-A1 NOVEL SUBSTITUTED BICYCLI AZA-HETEROCYCLES AS SOS1 INHIBITORS VIVA STAR BIOSCIENCES (SUZHOU) CO., LTD. (CN) 2022-09-09 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240109887-A1 NOVEL SUBSTITUTED BICYCLIC AZA-HETEROCYCLES AS SOS1 INHIBITORS SOS1, SOS2, KSR1 KDM4E 1518/4885ALDH1A1 3733/4885HPGD 3931/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback